J, K., U, M., & H, S. (2012). Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Kekow, Mueller-Ladner U, and Schulze-Koops H. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
MLA (8th ed.) CitationJ, Kekow, et al. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
Warning: These citations may not always be 100% accurate.